Retina/Vitreous

Top Story

TANZANITE study: No re-treatments required with triamcinolone acetonide formulation after 3 months

July 27, 2016

A majority of patients treated with a proprietary form of triamcinolone acetonide in combination with aflibercept required no additional treatments over 3 months compared with patients treated with aflibercept alone, Clearside Biomedical announced in a press release.

The phase 2 TANZANITE clinical trial included 46 treatment-naïve patients with macular edema associated with retinal vein occlusion who were randomized to receive suprachoroidally administered Zuprata (triamcinolone acetonide, Clearside) in combination with intravitreally administered Eylea (aflibercept, Regeneron) or Eylea alone.

BLOG: Reducing blue light at the source

July 26, 2016
A couple of months ago, Apple released its latest operating system, iOS 9.3, which includes Night Shift. With blue light in the 460 nm to 490 nm range being shown to…
Meeting News CoverageVideo

VIDEO: High-resolution OCT findings of macular disorders

July 24, 2016
At Retina 2016, Elias Reichel, MD, shares cases of high-resolution OCT findings of macular disorders from his practice.
Meeting News CoverageVideo

VIDEO: Speaker gives update on infectious uveitis

July 23, 2016
At Hawaiian Eye, Thomas A. Albini, MD, gives an update on infectious uveitis.
In the Journals

Macular carotenoids can have positive effects on visual function

July 19, 2016
Researchers found that in subjects free of retinal disease and with low macular pigment, supplementation with a…
More »
Meeting News Coverage

Latanoprostene bunod reduces IOP, ocular hypertension

July 20, 2016
BOSTON – Once daily latanoprostene bunod 0.024%, taken in the evening, reduced IOP in subjects with open angle…
More »
Featured
Optometry's Meeting 2016

Optometry's Meeting 2016

Perspectives on Glaucoma

Study: Perimetry detects progression before photography in eyes with field loss

July 21, 2016
Progression in the visual field was detected first, more than four times as often as progression in the optic disc, in…
More »

TANZANITE study: No re-treatments required with triamcinolone acetonide formulation after 3 months

July 27, 2016
A majority of patients treated with a proprietary form of triamcinolone acetonide in combination with aflibercept required no additional treatments…

BLOG: Reducing blue light at the source

July 26, 2016
A couple of months ago, Apple released its latest operating system, iOS 9.3, which includes Night Shift. With blue light in the 460 nm to 490 nm…

Meeting News CoverageVideo

VIDEO: High-resolution OCT findings of macular disorders

July 24, 2016
At Retina 2016, Elias Reichel, MD, shares cases of high-resolution OCT findings of macular disorders from his practice.

Meeting News CoverageVideo

VIDEO: Speaker gives update on infectious uveitis

July 23, 2016
At Hawaiian Eye, Thomas A. Albini, MD, gives an update on infectious uveitis.

Perspective

Argus II retinal prosthesis system shows continued safety, efficacy 5 years after implantation

July 21, 2016
The Argus II retinal prosthesis system restored some basic visual function at 5 years after implantation in patients who were blind from retinitis…

In the Journals

Half-dose or half-time PDT improves visual acuity, reduces subretinal fluid

July 20, 2016
Half-dose and half-time fluorescein angiography-guided photodynamic therapy yielded similar visual and anatomic results in the treatment of central…

In the Journals

Macular carotenoids can have positive effects on visual function

July 19, 2016
Researchers found that in subjects free of retinal disease and with low macular pigment, supplementation with a formulation containing carotenoids…

In the Journals

As-needed aflibercept resolves persistent, recurrent fluid in eyes with neovascular AMD

July 18, 2016
As-needed aflibercept injections improved anatomic outcomes in eyes with recurrent or persistent retinal fluid associated with neovascular…

Meeting News CoverageVideo

VIDEO: Speaker compares OCT systems

July 16, 2016
At Retina 2016, Andrew A. Moshfeghi, MD, MBA, gives a practical comparison of spectral domain OCT systems.

Meeting News Coverage

Professor credits neurodevelopmental optometry with his full recovery from TBI

July 15, 2016
BOSTON – In September 1999, Clark Elliott, PhD, was rear-ended at a stop sign, resulting in a concussion, and his long-term prognosis was…

More Headlines »
morganatic-roan